Search 

Image Analysis Group is a strategic partner to bio-pharmaceutical companies developing new treatments to improve patients’ lives. IAG broadly leverages its core imaging expertise, proprietary technology platform DYNAMIKA and capabilities to support an objective early go no/ go decision and drive excellence for tomorrow’s innovative therapeutic agents with speed.

IDACO Consulting Limited is a solution-oriented consultancy with a specific focus on supporting companies in the Pharmaceutical, Biotechnology, Medical Device, Life Science and Healthcare sectors.
 
Using our pre-clinical and clinical expertise, along with an extensive network of academic, outsourcing and commercial contacts, we support the development and commercialisation of bio-pharmaceutical products and medical devices.

Our service offering includes:

Pharmaceutical, Medical Device & Healthcare Consulting

    ·   Pre-Clinical & Clinical Development
    ·   Strategy Development & Implementation
    ·   Medical Affairs,  Medical Education & Market Access Support
    ·   Regulatory & Post-Approval Services

Technical Due Diligence, Gap Analysis & Remediation

Business Development

    ·   ​Sourcing Collaborative & Licensing Opportunities
    ·   Providing Out-Licensing Support
    ·   Bridging Academia to Industry and Industry to Academia

​IDACO Consulting also supports clients who are looking to identify new opportunities for collaboration and licensing through its extensive and purpose-built network of technology transfer and business developments contacts. We have access to over 400 universities and research institutions across 26 European countries.

Inivata is a global clinical cancer genomics company utilizing a proprietary, industry-leading liquid biopsy platform to transform patient care.  Using a simple blood test (liquid biopsy), the analysis of ctDNA is a new lower-cost, less invasive, highly sensitive method for oncologists to diagnose and monitor cancer progression and treatment. The InVision™ liquid biopsy platform, based on pioneering research from the Rosenfeld Lab at the Cancer Research UK Cambridge Institute (CRUK-CI), University of Cambridge, combines industry-leading sensitivity with a select multi-gene panel to provide clinically actionable information to clinicians. Inivata has established collaborations with world-leading cancer centers and academic institutions, and is partnering with pharmaceutical and biotechnology companies.  The Company has a CLIA lab in Research Triangle Park, NC and laboratories in Cambridge, UK. For more information, please go to www.inivata.com. Follow us on Twitter @Inivata.